VistaGen Therapeutics, Inc. (VTGN) CEO Shawn Singh on Q1 2022 Results - Earnings Call Transcript
VistaGen Therapeutics, Inc. (VTGN) CEO Shawn Singh on Q1 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
CymaBay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
Vivos Therapeutics, Inc. (VVOS) CEO Kirk Huntsman on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
The AZEK Company Inc. (AZEK) CEO Jesse Singh on Q3 2021 Results - Earnings Call Transcript
SeekingAlpha
-
VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
Entasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha
-
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2021 Results - Earnings Call Transcript
SeekingAlpha